Villere St Denis J & CO LLC Ligand Pharmaceuticals Inc Transaction History

Villere St Denis J & CO LLC

$1.15 Billion
Q3 2024

A detailed history of Villere St Denis J & CO LLC transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Villere St Denis J & CO LLC holds 474,858 shares of LGND stock, worth $54.4 Million. This represents 4.12% of its overall portfolio holdings.

Number of Shares

474,858

Previous 483,913 1.87%

Holding current value

$54.4 Million

Previous $40.8 Million 16.66%

% of portfolio

4.12%

Previous 3.66%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$82.7 - $110.11 $748,848 - $997,046	-9,055 Reduced 1.87%	474,858 $47.6 Million
Q2 2024 Aug 06, 2024	SELL	$68.53 - $87.91 $468,676 - $601,216	-6,839 Reduced 1.39%	483,913 $40.8 Million
Q1 2024 Apr 25, 2024	BUY	$68.64 - $89.2 $4.3 Million - $5.59 Million	62,701 Added 14.65%	490,752 $35.9 Million
Q4 2023 Jan 25, 2024	SELL	$49.57 - $72.63 $501,152 - $734,289	-10,110 Reduced 2.31%	428,051 $30.6 Million
Q3 2023 Oct 20, 2023	SELL	$58.86 - $72.67 $2.43 Million - $3 Million	-41,286 Reduced 8.61%	438,161 $26.3 Million
Q2 2023 Jul 18, 2023	SELL	$69.53 - $79.33 $94,560 - $107,888	-1,360 Reduced 0.28%	479,447 $34.6 Million
Q1 2023 Apr 25, 2023	SELL	$65.67 - $77.08 $166,801 - $195,783	-2,540 Reduced 0.53%	480,807 $35.4 Million
Q4 2022 Jan 18, 2023	SELL	$61.72 - $96.74 $478,947 - $750,702	-7,760 Reduced 1.58%	483,347 $32.3 Million
Q3 2022 Oct 17, 2022	SELL	$0.01 - $107.56 $49 - $529,302	-4,921 Reduced 0.99%	491,107 $42.3 Million
Q2 2022 Jul 18, 2022	SELL	$74.52 - $117.06 $1.1 Million - $1.73 Million	-14,815 Reduced 2.9%	496,028 $44.3 Million
Q1 2022 Apr 19, 2022	SELL	$94.99 - $151.56 $773,693 - $1.23 Million	-8,145 Reduced 1.57%	510,843 $57.5 Million
Q4 2021 Jan 19, 2022	SELL	$127.69 - $165.85 $5.79 Million - $7.52 Million	-45,361 Reduced 8.04%	518,988 $80.2 Million
Q3 2021 Oct 19, 2021	SELL	$102.33 - $144.73 $3.07 Million - $4.35 Million	-30,031 Reduced 5.05%	564,349 $78.6 Million
Q2 2021 Jul 19, 2021	BUY	$113.03 - $155.64 $6.48 Million - $8.93 Million	57,352 Added 10.68%	594,380 $78 Million
Q1 2021 Apr 19, 2021	SELL	$99.52 - $215.83 $10.5 Million - $22.7 Million	-105,045 Reduced 16.36%	537,028 $81.9 Million
Q4 2020 Jan 26, 2021	SELL	$80.55 - $106.05 $1.72 Million - $2.26 Million	-21,310 Reduced 3.21%	642,073 $63.9 Million
Q3 2020 Oct 27, 2020	BUY	$89.56 - $126.72 $1.41 Million - $1.99 Million	15,715 Added 2.43%	663,383 $63.2 Million
Q2 2020 Jul 29, 2020	BUY	$68.28 - $123.65 $813,214 - $1.47 Million	11,910 Added 1.87%	647,668 $72.4 Million
Q1 2020 Apr 30, 2020	BUY	$63.37 - $107.88 $40.3 Million - $68.6 Million	635,758 New	635,758 $46.2 Million

Others Institutions Holding LGND

# of Institutions

256

Shares Held

18.1M

Call Options Held

26.8K

Put Options Held

9.3K

View Full List

About LIGAND PHARMACEUTICALS INC

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.94B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

More about LGND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Villere St Denis J & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Villere St Denis J & CO LLC with notifications on news.

Account

Villere St Denis J & CO LLC Ligand Pharmaceuticals Inc Transaction History